Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTHar Gel Dosing in Proliferative Lupus Nephritis
NCT02226341Phase 4Terminated
- Sponsor
- Columbia University
- Start
- Oct 2014
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in lupus nephritis (LN), sponsored by Columbia University. Started Oct 2014; status: terminated.
02
Drugs
repository corticotropin injection
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on NCT02226341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02226341.